CRISPR THERAPEUTICS AG earnings per share and revenue

CRSP/N earnings per share for the last quarter are -19.90 MXN whereas the estimation was -27.28 MXN which accounts for 27.06% surprise. Company revenue for the same period amounts to 11.86 M MXN despite the estimated figure of 129.39 M MXN. Estimated earnings per share for the next quarter are -25.21 MXN, and revenue is expected to reach 161.83 M MXN. Also watch annual changes over time to get a bigger picture of CRSP/N earnings per share and revenue dynamics.